Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
304.00
+3.00 (1.00%)
Apr 3, 2026, 3:30 PM KST

Aprogen Medicines Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
45,14837,16235,68443,07015,894
Short-Term Investments
----4,000
Trading Asset Securities
5,6126,5005,0004,390-
Cash & Short-Term Investments
50,76043,66240,68447,46019,894
Cash Growth
16.26%7.32%-14.28%138.57%-91.62%
Accounts Receivable
25,97619,67424,80921,3891,567
Other Receivables
3,5581,1701,6077,9889,759
Receivables
60,61224,35634,63792,30656,990
Inventory
60,89462,48360,81561,46723,257
Prepaid Expenses
1,179967.42847.35913.48906.58
Other Current Assets
5,1992,8497,2249,4322,052
Total Current Assets
178,643134,317144,207211,578103,099
Property, Plant & Equipment
367,267364,181362,959365,100314,479
Long-Term Investments
19,2969,7902,4473,29854,786
Goodwill
50,958----
Other Intangible Assets
17,4156,1067,4898,4312,633
Long-Term Deferred Tax Assets
2,683--662.84-
Long-Term Deferred Charges
54,42046,60134,6254,988-
Other Long-Term Assets
22,7883,9021,2245,2221,904
Total Assets
717,265609,968594,428599,853477,646
Accounts Payable
5,0143,4232,7344,1863,920
Accrued Expenses
4,4452,6832,5564,1178,410
Short-Term Debt
101,11435,78446,63149,763398,613
Current Portion of Long-Term Debt
45,00045,00044,9387,675-
Current Portion of Leases
1,030592.23560.08934.882,785
Current Income Taxes Payable
-246.72-4.18-
Current Unearned Revenue
234.25----
Other Current Liabilities
26,93225,23128,22223,2538,202
Total Current Liabilities
183,769112,959125,64089,933421,929
Long-Term Debt
40,00032,00032,00031,25131,046
Long-Term Leases
718.46326.69288.35571.0319,925
Pension & Post-Retirement Benefits
16,83515,69411,74010,3194,076
Long-Term Deferred Tax Liabilities
8,7346,5905,3755,3221,167
Other Long-Term Liabilities
8,5982,3081,6961,455309.39
Total Liabilities
258,655169,878176,740138,851478,453
Common Stock
164,653152,062132,419126,834260,351
Additional Paid-In Capital
521,069512,886472,949431,64146,794
Retained Earnings
-488,200-418,506-358,604-293,691-192,837
Treasury Stock
-98,115-98,115-98,115-98,084-
Comprehensive Income & Other
58,90410,306-849.6748,392-112,146
Total Common Equity
158,310158,634147,800215,0922,163
Minority Interest
300,300281,457269,888245,910-2,970
Shareholders' Equity
458,610440,091417,688461,002-806.44
Total Liabilities & Equity
717,265609,968594,428599,853477,646
Total Debt
187,862113,702124,41790,195452,369
Net Cash (Debt)
-137,102-70,041-83,732-42,736-432,475
Net Cash Per Share
-460.90-271.34-354.54-211.16-2494.46
Filing Date Shares Outstanding
308.06283.37244.08232.9366.38
Total Common Shares Outstanding
308.06283.37244.08232.9366.38
Working Capital
-5,12621,35718,567121,644-318,829
Book Value Per Share
513.89559.82605.54923.4232.59
Tangible Book Value
89,938152,528140,311206,661-469.92
Tangible Book Value Per Share
291.95538.27574.86887.23-7.08
Land
60,08150,01244,13644,19012,484
Buildings
122,711115,772115,622113,61188,041
Machinery
268,124221,978195,122191,265137,051
Construction In Progress
29,56661,140107,58088,23485,017
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.